Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology ROE 2010-2024 | POAI

Current and historical return on equity (ROE) values for Predictive Oncology (POAI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Predictive Oncology ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $-0.01B $0.00B -480.00%
2024-09-30 $-0.01B $0.00B -288.89%
2024-06-30 $-0.01B $0.00B -185.71%
2024-03-31 $-0.01B $0.00B -143.59%
2023-12-31 $-0.01B $0.01B -96.30%
2023-09-30 $-0.02B $0.01B -105.88%
2023-06-30 $-0.02B $0.02B -88.37%
2023-03-31 $-0.03B $0.02B -95.24%
2022-12-31 $-0.03B $0.02B -81.30%
2022-09-30 $-0.03B $0.03B -70.92%
2022-06-30 $-0.03B $0.03B -65.41%
2022-03-31 $-0.02B $0.04B -42.70%
2021-12-31 $-0.02B $0.04B -45.20%
2021-09-30 $-0.02B $0.05B -65.71%
2021-06-30 $-0.03B $0.05B -96.15%
2021-03-31 $-0.03B $0.04B -165.08%
2020-12-31 $-0.03B $0.00B -291.89%
2020-09-30 $-0.03B $0.01B -266.67%
2020-06-30 $-0.03B $0.01B -200.00%
2020-03-31 $-0.02B $0.01B -137.50%
2019-12-31 $-0.02B $0.01B -148.15%
2019-09-30 $-0.01B $0.02B -83.72%
2019-06-30 $-0.01B $0.02B -128.00%
2019-03-31 $-0.01B $0.00B -733.33%
2018-12-31 $-0.01B $0.00B -363.64%
2018-09-30 $-0.01B $0.00B -228.57%
2018-06-30 $-0.01B $0.00B -184.62%
2018-03-31 $-0.01B $0.01B -215.38%
2017-12-31 $-0.01B $0.00B -200.00%
2017-09-30 $-0.01B $0.00B -240.00%
2017-06-30 $-0.01B $0.00B -300.00%
2017-03-31 $-0.01B $0.00B -400.00%
2016-12-31 $-0.01B $0.00B -560.00%
2016-09-30 $-0.01B $0.00B -400.00%
2016-06-30 $-0.01B $0.00B -228.57%
2016-03-31 $-0.01B $0.00B -342.86%
2015-12-31 $0.00B $0.00B 800.00%
2015-09-30 $0.00B $0.01B 133.33%
2015-06-30 $0.00B $-0.01B 72.73%
2015-03-31 $-0.01B $-0.01B 105.26%
2014-12-31 $-0.01B $-0.01B 186.67%
2014-09-30 $-0.01B $0.00B 233.33%
2014-06-30 $-0.01B $0.00B 444.44%
2014-03-31 $-0.01B $0.00B 400.00%
2013-12-31 $-0.01B $0.00B 360.00%
2013-09-30 $-0.01B $0.00B 360.00%
2013-06-30 $-0.01B $0.00B 290.91%
2013-03-31 $-0.01B $0.00B 360.00%
2012-12-31 $-0.01B $0.00B 320.00%
2012-09-30 $-0.01B $0.00B 360.00%
2012-06-30 $-0.01B $0.00B 280.00%
2012-03-31 $-0.01B $0.00B 200.00%
2011-12-31 $0.00B $0.00B 177.78%
2011-09-30 $0.00B $0.00B 50.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 50.00%
2010-09-30 $0.00B $0.00B 50.00%
2010-06-30 $0.00B $0.00B 100.00%
2010-03-31 $0.00B $0.00B 200.00%
2009-12-31 $0.00B $0.00B 300.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.008B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.134B 48.53
Tempus AI (TEM) United States $6.966B 0.00
Hims & Hers Health (HIMS) United States $6.050B 97.25
Inspire Medical Systems (INSP) United States $4.470B 86.83
IRhythm Technologies (IRTC) United States $3.223B 0.00
Privia Health (PRVA) United States $2.873B 215.27
Schrodinger (SDGR) United States $1.881B 0.00
Clover Health Investments (CLOV) United States $1.839B 0.00
Enovis (ENOV) United States $1.825B 11.29
Omnicell (OMCL) United States $1.418B 30.59
Phreesia (PHR) United States $1.409B 0.00
Azenta (AZTA) United States $1.154B 53.72
10x Genomics (TXG) United States $0.918B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.551B 0.00
Talkspace (TALK) United States $0.450B 267.00
Veradigm (MDRX) United States $0.449B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.363B 0.00
Claritev (CTEV) United States $0.325B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
Pulmonx (LUNG) United States $0.182B 0.00
American Well (AMWL) United States $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.100B 0.00
Retrieve Medical Holdings (RMHI) United States $0.082B 0.00
MDxHealth SA (MDXH) Belgium $0.076B 0.00
P3 Health Partners (PIII) United States $0.066B 0.00
111 (YI) China $0.064B 0.00
CareCloud (CCLD) United States $0.060B 2.58
HeartBeam (BEAT) United States $0.055B 0.00
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Precipio (PRPO) United States $0.009B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Syra Health (SYRA) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00